Cancer Outpatients at Greater Risk for Blood Clots
In large study, only one-quarter of patients developed clots in hospitalContinue Reading
FDA Panel Cites Clot Risk From Contraceptive Patch
Advisory group recommends Ortho Evra remain available, but with warning on labelContinue Reading
Adult Sickle Cell Drug May Benefit Kids, Too
It was well-tolerated by children younger than 4, study findsContinue Reading
Gene Therapy a Boon for 6 Hemophilia Patients
Severity of the bleeding condition was reduced for men with type B disorder, study findsContinue Reading
Low-Dose Aspirin After Lung Clot Could Prevent Recurrence
Study shows benefit for patients who’ve already finished with stronger blood thinnersContinue Reading
FDA Panels to Weigh Safety of Newer Forms of the 'Pill'
They will consider new warning labels about increased risk of blood clots linked to contraceptivesContinue Reading
Sickle Cell Disease Tied to 'Silent Strokes' in Children
Anemia and high blood pressure together or alone increased the risk in study of young patientsContinue Reading
FDA Moves to Speed Development of Artificial Pancreas Systems
Agency suggests more flexible requirements for clinical trials leading to approvalContinue Reading
Self-Monitoring of Blood Thinner May Halve Clot Risk
But newer drugs may replace warfarin and the need for frequent blood tests, experts sayContinue Reading
More Aggressive Chemo May Help Younger Lymphoma Patients: Study
High-dose combination therapy boosts disease-free survival but raises side-effect riskContinue Reading
Newer Blood Thinner May Pose Danger to Trauma Patients
Pradaxa has caused severe bleeding problems that can’t be reversed, trauma surgeon saysContinue Reading
Blood Type May Be Associated With Stroke Risk: Study
Researchers say type AB raised chance of attack by 26%, but there’s no proof of cause-and-effectContinue Reading
Jakafi Approved for Rare Bone-Marrow Disease
First drug in U.S. sanctioned for myelofibrosisContinue Reading